Related Experiment Videos
[Meticillin resistant Staphylococcus aureus in Norway].
Petter Elstrøm1, Preben Aavitsland
1Avdeling for infeksjonsovervåking Nasjonalt folkehelseinstitutt Postboks 4404 Nydalen 0403 Oslo. petter.elstrom@fhi.no
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing in Nordic countries, necessitating updated treatment guidelines. A "search and destroy" strategy is recommended, focusing on high-risk individuals and healthcare settings to curb MRSA spread.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Context:
- Staphylococcus aureus, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant threat in healthcare settings and among vulnerable populations.
- MRSA infections are associated with increased morbidity and mortality compared to sensitive strains.
- The rising incidence of MRSA necessitates a re-evaluation of current treatment and control strategies.
Purpose:
- To review the current literature and national guidelines regarding MRSA prevention and control.
- To inform the development of updated guidelines for empirical treatment of staphylococcal infections.
- To analyze the incidence and strategic approaches to MRSA in Nordic countries and the Netherlands.
Summary:
- The incidence of MRSA, while historically low in Nordic countries, is on the rise.
- A "search and destroy" strategy is employed in the Netherlands and Nordic countries, with variations in implementation.
- Proposed Norwegian guidelines suggest a "search and destroy" approach within hospitals, targeting high-risk individuals outside healthcare to prevent transmission.
Impact:
- Updated treatment guidelines may increase healthcare costs but are crucial for managing MRSA.
- Accelerated evolution of bacterial resistance is a concern.
- Effective MRSA control strategies are vital to mitigate severe infections and improve patient outcomes.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...